Safety and Adverse Effects of Inactive SARS-Cov-2 Vaccine (CoronaVac) in Health Care Professionals

Küçük Resim Yok

Tarih

2022

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Pakistan Medical Association

Erişim Hakkı

info:eu-repo/semantics/closedAccess

Özet

Objective: To assess adverse effects post-vaccination in healthcare professionals in the first vaccinated group against coronavirus disease-2019. Method: The prospective study was conducted at the vaccination unit of a university hospital in Tekirdag, Turkey, from January to February 2021, and comprised healthcare professionals who came for receiving the second dose of the coronavirus disease-2019 inactivated severe acute respiratory syndrome coronavirus 2 vaccine 28 days after the first dose. Data was analysed using SPSS 18. Results: Of the 1088 subjects, 714(65.6%) were female with mean age 29.85±9.2 years and 374(34.4%) were male with mean age 29.57±9.85 years. Overall, local pain in the vaccinated area 495(45.5%), fatigue 266(24.4%), headache 261(23.9%) and muscle pain 197(18.1%) were very common adverse effects. Conclusion: Inactivated severe acute respiratory syndrome coronavirus 2 vaccine was found to be safe. © 2022 Pakistan Medical Association. All rights reserved.

Açıklama

Anahtar Kelimeler

CoronaVac, Healthcare professionals, Post-vaccination adverse effects, coronavac, adult, adverse drug reaction, ageusia, anosmia, arthralgia, Article, coronavirus disease 2019, coughing, descriptive research, diarrhea, drug safety, epiphora, fatigue, female, fever, headache, health care personnel, human, injection site pain, loss of appetite, lymphadenopathy, male, myalgia, nausea and vomiting, nose obstruction, polymerase chain reaction, prospective study, rash, rhinorrhea, Severe acute respiratory syndrome coronavirus 2, skin redness, skin tingling, sore throat, swelling, Turkey (republic), vaccination

Kaynak

Journal of the Pakistan Medical Association

WoS Q Değeri

Q4

Scopus Q Değeri

Q4

Cilt

72

Sayı

9

Künye